Search Within

Richard Bambury

Formats
  1. Meeting Abstract (19)
  2. Journal Article (14)
  3. Book Section (1)
Groups
  1. Department of Medicine (28)
  2. Solid Tumor Oncology Division (28)
  3. Genitourinary Oncology Service (27)
  4. Biostatistics Service (8)
  5. Epidemiology and Biostatistics (8)
  6. GSK Faculty (5)

More Groups

People
  1. Jonathan Rosenberg (16)
  2. Gopakumar Iyer (12)
  3. Dean Bajorin (8)
  4. Howard Scher (8)
  5. Irina Ostrovnaya (6)
  6. Nicole Schreiber (6)

More People

Years
  1. 2018 (3)
  2. 2016 (4)
  3. 2015 (13)
  4. 2014 (8)
  5. 2013 (6)
Publications
  1. Journal of Clinical Oncology (16)
  2. Annals of Oncology (2)
  3. Urologic Oncology: Seminars and Original Investigations (2)
  4. Anti-Cancer Drugs (1)
  5. BMC Cancer (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (16)
  2. Elsevier Inc. (3)
  3. Oxford University Press (3)
  4. Springer (3)
  5. American Association for Cancer Research (2)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and tolerability of adjuvant FOLFOX vs. CAPOX in colon cancer: A real-world experience
    Meeting Abstract

    Mullally, W. J.; Naeem, A.; Dennehy, C.; Goggin, C.; Gleeson, J. P.; Greene, J. P.; Dawod, M. A. I.; O'Reilly, S.; O'Mahony, D.; Power, D. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Cost saving analysis of reduced-dose versus standard-dose bevacizumab in recurrent glioblastoma
    Meeting Abstract

    Gleeson, J. P.; Greene, J. P.; Mullally, W. J.; Brady, C.; Goggin, C.; Dennehy, C.; Power, D. G.; Hennessy, B.; Breathnach, O. S.; Bambury, R. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Real world experience with pembrolizumab and nivolumab for treatment of non-small cell lung cancer (NSCLC) in an Irish Regional Cancer Center
    Meeting Abstract

    Dennehy, C.; Mullally, W.; Goggin, C.; Gleeson, J. P.; Greene, J. P.; Power, D. G.; O'Reilly, S.; Collins, D. C.; O'Mahony, D.; Bambury, R. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genomic landscape of defective DNA damage response and repair mechanisms (DDR) across cancer types
    Meeting Abstract

    Teo, M.; Zabor, E. C.; Iyer, G.; Bambury, R.; Boyd, M. E.; Rosenberg, J. E.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Impact of AR-V7 protein localization in the prediction of therapeutic benefit of taxanes over androgen receptor signaling inhibitors (ARSi) in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Scher, H.; Graf, R.; Schreiber, N.; Lu, D.; Louw, J.; Alvarez, H. A. V.; Bambury, R.; Danila, D.; McLaughlin, B.; Heller, G.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Association of AR-V7 on circulating tumor cells as a treatment-specific biomarker with outcomes and survival in castration-resistant prostate cancer
    Journal Article

    Scher, H. I.; Lu, D.; Schreiber, N. A.; Louw, J.; Graf, R. P.; Vargas, H. A.; Johnson, A.; Jendrisak, A.; Bambury, R.; Danila, D.; more...
    JAMA Oncology (2016)

    Fulltext@MSK | Save
  • Novel and next-generation androgen receptor-directed therapies for prostate cancer: Beyond abiraterone and enzalutamide
    Journal Article

    Bambury, R. M.; Rathkopf, D. E.
    Urologic Oncology: Seminars and Original Investigations (2016)

    Fulltext@MSK | Save
  • Clinical trials and emerging therapeutic strategies in bladder cancer
    Book Section

    Bambury, R. M.; Sims, R. B.; Rosenberg, J. E.
    In Konety, B. R.; Chang, S. S. (Eds.) Management of Bladder Cancer: A Comprehensive Text With Clinical Scenarios (2015)

    Fulltext@MSK | Save
  • Single cell analysis of AR N terminal, AR C terminal and the ARv7 splice variant in the CTCs of metastatic castration resistant prostate cancer (mCRPC) patients
    Meeting Abstract

    Kelvin, J.; Lu, D.; Packer, D.; Bambury, R.; Rathkopf, D.; Schreiber, N.; Arslan, Z.; Prigozhina, N.; Brown, D.; Krupa, R.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Presence of AR-V7 splice variant or AR C terminal loss in the CTCs of mCRPC patients identifies patients with improved PSA response with taxanes over androgen receptor signaling directed therapies (ARS Rx)
    Meeting Abstract

    Scher, H. I.; Kelvin, J.; Lu, D.; Louw, J.; Packer, D.; Bambury, R.; Rathkopf, D.; Schreiber, N.; Brennan, R.; Prigozhina, N.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save